Bobustuc, G. C., Baker, C. H., Limaye, A., Jenkins, W. D., Pearl, G., Avgeropoulos, N. G., & Konduri, S. D. (2010). Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Oxford University Press.
Citación estilo ChicagoBobustuc, George C., Cheryl H. Baker, Arati Limaye, Wayne D. Jenkins, Gary Pearl, Nicholas G. Avgeropoulos, y Santhi D. Konduri. Levetiracetam Enhances P53-mediated MGMT Inhibition and Sensitizes Glioblastoma Cells to Temozolomide. Oxford University Press, 2010.
Cita MLABobustuc, George C., et al. Levetiracetam Enhances P53-mediated MGMT Inhibition and Sensitizes Glioblastoma Cells to Temozolomide. Oxford University Press, 2010.
Precaución: Estas citas no son 100% exactas.